Shares & Derivatives
China Animal – A potential double bottom in the making?
By Ernest Lim's investing blog  •  June 13, 2011
China Animal Healthcare Ltd. (“CAL”) seems to be on the verge of completing a double bottom formation, if it can break the neckline at $0.280 with volume expansion.
For the uninitiated, CAL has three main business divisions outlined in Table 1 below.
Table 1: Outline of the respective business divisions
S/No
Business division
Percentage of FY10 revenue
Remarks
a)
Powdered drugs
69.6%
Usually for poultry such as chickens as they have no taste buds. Marketed through its extensive retail network.
b)
Injection drugs
5.7%
More applicable for livestock such as pigs, cows and sheep. Marketed through its extensive retail network.
c)
Biological drugs
24.7%
Mainly in the form of vaccines and applicable to all poultry and livestock.
Non mandatory vaccines: Marketed through its extensive retail network.
Mandatory vaccines: Marketed to governmental provincial veterinary stations through semi annual public tenders (Aug & Feb)
Source: Company
Below is ...
...
Read the full article
By Ernest Lim's investing blog
I am an avid investor, trader cum remisier. I am a Chartered Financial Analyst® charterholder, as well as, a Chartered Accountant of Singapore. I have published articles on a wide range of topics on finance and investment, ranging from market / sector outlook, technical analysis and fundamental analysis etc.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance